Evonik launches RESOMER® for bioresorbable implants

Evonik, a global leader in biomaterials for medical implants, recently announced the launch of a new line of RESOMER® Filaments to enable the 3D printing of personalized, high-resolution bioresorbable implants.

Spools of high-quality filaments based on medical grade RESOMER® are supplied ready to use for Fused Filament Fabrication (FFF), also known as Fused Deposition Modelling (FDM), 3D printing systems. The design of tight dimensional and chemical specifications of RESOMER® Filaments enables reproducible implant properties and performance for high-resolution 3D printing applications.

A selection of Poly(L-lactide) (PLLA), Poly (L-lactide-co-glycolide) (PLGA), Poly(caprolactone) (PCL) and Polydioxanone (PDO) grades are available as standard grades, with additional customization options available upon request. Mechanical properties such as strength and elongation at break can be tailored to the target application, with bioresorption periods ranging from less than six months to more than three years.